Method
Clinical, biochemical parameters and ultrasound scan(USS) of liver were
performed at the baseline to assess NAFLD. Excluding pregnant women who
reported any type of hyperglycemia at the baseline, the cohort was
followed up to assess the occurrence of GDM (using latest WHO criteria)
during 24-28 weeks of gestation. Miscarriages were documented.